Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Return to: PBR Home | Contract Research & Services
Today in Contract Research & Services

Contract Research & Services

Sanofi plans to increase presence in Iran Sanofi has signed a Memorandum of Cooperation (MoC) with the Government of Iran intended at increasing its presence in the country. Contract Research & Services > Contract Research > News

Latest Contract Research & Services News by Sector

Select a sector from the list or browse by sector below:

Clinical Trials

Cancer Research UK starts phase 1/1b clinical trial of taladegib in combination with paclitaxel
Ignyta announced that Cancer Research UK has initiated a new, investigator-sponsored Phase 1/1b clinical trial of a combination of paclitaxel with taladegib - the company's novel, orally available, hedgehog/smoothened inhibitor - in patients with platinum-resistant, recurrent ovarian cancer or recurrent, advanced solid tumors.
Contract Research & Services > Clinical Trials > News
Juventas enrolls first patient in phase 2 gene therapy clinical trial
Juventas Therapeutics is enrolling its STOP-PAD trial, a 120-patient, placebo-controlled, randomized double-blinded Phase 2 study evaluating the safety and efficacy of JVS-100, a gene therapy encoding human stromal cell-derived factor-1 (SDF-1), in patients with advanced peripheral artery disease (PAD)
Contract Research & Services > Clinical Trials > News

Contract Research

GSK, Adaptimmune Therapeutics expand cancer immunotherapy alliance
By PBR Staff Writer
Pharmaceutical firms GlaxoSmithKline (GSK) and Adaptimmune Therapeutics have expanded their immunotherapy collaboration.
Contract Research & Services > Contract Research > News
Sanofi plans to increase presence in Iran
By PBR Staff Writer
Sanofi has signed a Memorandum of Cooperation (MoC) with the Government of Iran intended at increasing its presence in the country.
Contract Research & Services > Contract Research > News

Contract Services

Seattle Genetics unveils commercial and regulatory progress under ADCETRIS collaboration with Takeda
Seattle Genetics will receive a one-time $20m milestone payment under its ADCETRIS (brentuximab vedotin) collaboration with Takeda Pharmaceutical Company Limited (Takeda).
Contract Research & Services > Contract Services > News
Takeda secures rights to Mersana’s XMT-1522 outside US and Canada
Mersana Therapeutics and Takeda Pharmaceutical Company have entered a new strategic partnership granting Takeda rights to Mersana’s lead product candidate, XMT-1522, outside the US and Canada.
Contract Research & Services > Contract Services > News